Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Weber

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transfusion|April 9, 2024
Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapyNilu Perera, Shoma Baidya, Nicholas Weber, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
An Individualized Exercise Intervention for People with Multiple Myeloma-Study Protocol of a Randomized Waitlist-Controlled TrialJennifer L Nicol, Carmel Woodrow, Brent J Cunningham, et al.
Frontiers in Immunology|March 12, 2024
An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemiaMd Ashik Ullah, Beatriz Garcillán, Eden Whitlock, et al.
Internal Medicine Journal|August 5, 2025
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma AustraliaGeorgia McCaughan, Hayley Beer, Christian Bryant, et al.
Bone Marrow Transplantation|August 15, 2022
High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantationYin Yuan, Philip Wong, Jason P Butler, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
Internal Medicine Journal|January 8, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupShirlene Sim, Georgia McCaughan, Andrew Zannettino, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Blood Advances|May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16Peter Mollee, John Reynolds, Wojt Janowski, et al.
British Journal of Haematology|May 11, 2026
Authors' reply to 'Comments on dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy'Ashleigh P Scott, Ada Lo, Ying Xia, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transfusion|April 9, 2024
Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapyNilu Perera, Shoma Baidya, Nicholas Weber, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
An Individualized Exercise Intervention for People with Multiple Myeloma-Study Protocol of a Randomized Waitlist-Controlled TrialJennifer L Nicol, Carmel Woodrow, Brent J Cunningham, et al.
Frontiers in Immunology|March 12, 2024
An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemiaMd Ashik Ullah, Beatriz Garcillán, Eden Whitlock, et al.
Internal Medicine Journal|August 5, 2025
Management of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplantation: position statement of the Medical and Scientific Advisory Group of Myeloma AustraliaGeorgia McCaughan, Hayley Beer, Christian Bryant, et al.
Bone Marrow Transplantation|August 15, 2022
High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantationYin Yuan, Philip Wong, Jason P Butler, et al.
Medicine and Science in Sports and Exercise|August 3, 2023
Safety, Feasibility, and Acceptability of a Multisite Individualized Exercise Intervention for People with Multiple MyelomaJennifer L Nicol, Brent J Cunningham, Carmel Woodrow, et al.
Internal Medicine Journal|January 8, 2026
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupShirlene Sim, Georgia McCaughan, Andrew Zannettino, et al.
Internal Medicine Journal|May 30, 2026
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman diseaseDipti Talaulikar, Jun Yen Ng, Adam Bryant, et al.
Blood Advances|May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16Peter Mollee, John Reynolds, Wojt Janowski, et al.
British Journal of Haematology|May 11, 2026
Authors' reply to 'Comments on dose-dependent impairment of brain functional and microstructural connectivity during leukaemia chemotherapy'Ashleigh P Scott, Ada Lo, Ying Xia, et al.
Pageof 4